AI platform for drug discovery

Auransa is a clinical stage, AI-native biopharma with a proprietary AI platform that harnesses available human disease data to discover novel therapeutics and raise the standard of cancer care. Its platform mines heterogeneous human disease data, including 525,000+ gene expression profiles, to discover novel therapies for the most responsive patients. The company is advancing studies in liver cancer, heart-safe chemotherapy, and more, and partners with leading pharmaceutical companies and academic institutions.

Read more

drug discovery programsgene expression profile analysismining human disease dataprecision medicine